JP2025517509A5 - - Google Patents
Info
- Publication number
- JP2025517509A5 JP2025517509A5 JP2024569498A JP2024569498A JP2025517509A5 JP 2025517509 A5 JP2025517509 A5 JP 2025517509A5 JP 2024569498 A JP2024569498 A JP 2024569498A JP 2024569498 A JP2024569498 A JP 2024569498A JP 2025517509 A5 JP2025517509 A5 JP 2025517509A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- patient
- administered
- daily
- hydrochloride monohydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263344917P | 2022-05-23 | 2022-05-23 | |
| US63/344,917 | 2022-05-23 | ||
| PCT/US2023/067326 WO2023230451A2 (en) | 2022-05-23 | 2023-05-23 | Methods of treating spinocerebellar ataxias |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517509A JP2025517509A (ja) | 2025-06-05 |
| JP2025517509A5 true JP2025517509A5 (https=) | 2026-04-03 |
Family
ID=88920175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024569498A Pending JP2025517509A (ja) | 2022-05-23 | 2023-05-23 | 脊髄小脳失調症を治療する方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4529485A2 (https=) |
| JP (1) | JP2025517509A (https=) |
| KR (1) | KR20250020409A (https=) |
| CN (1) | CN120018855A (https=) |
| WO (1) | WO2023230451A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP2400349A1 (hu) * | 2024-07-05 | 2026-01-28 | Egis Gyógyszergyár Zrt. | Troriluzole-hidroklorid-sók |
| WO2026062600A1 (en) * | 2024-09-22 | 2026-03-26 | Biohaven Therapeutics Ltd. | Troriluzole for use in treating spinocerebellar ataxias |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3585900B1 (en) * | 2017-02-22 | 2022-12-21 | CRISPR Therapeutics AG | Materials and methods for treatment of spinocerebellar ataxia type 2 (sca2) and other spinocerebellar ataxia type 2 protein (atxn2) gene related conditions or disorders |
| EP4483956B1 (en) * | 2017-11-12 | 2025-12-31 | Biohaven Therapeutics Ltd. | TRORILUZOLE INTENDED FOR USE IN THE TREATMENT OF SPINOCEREBELLOUS ATAXIA 3 (SCA3) |
| US20210308111A1 (en) * | 2018-07-27 | 2021-10-07 | With Great Power, Llc | Clinical Methods And Pharmaceutical Compositions Employing AMPA Receptor Antagonists To Treat Glioblastoma And Other Cancers |
| US20230067811A1 (en) * | 2020-01-24 | 2023-03-02 | University Of Virginia Patent Foundation | Modulating lymphatic vessels in neurological disease |
-
2023
- 2023-05-23 WO PCT/US2023/067326 patent/WO2023230451A2/en not_active Ceased
- 2023-05-23 KR KR1020247038718A patent/KR20250020409A/ko active Pending
- 2023-05-23 JP JP2024569498A patent/JP2025517509A/ja active Pending
- 2023-05-23 EP EP23812702.1A patent/EP4529485A2/en active Pending
- 2023-05-23 CN CN202380041989.8A patent/CN120018855A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200916103A (en) | Therapeutic compositions and methods | |
| TW200412934A (en) | Pharmaceutical formulations of modafinil | |
| JP2023535744A5 (https=) | ||
| JP2025517509A5 (https=) | ||
| JP2010532372A5 (https=) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2021502392A5 (https=) | ||
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2019501881A5 (https=) | ||
| JP2023523706A5 (https=) | ||
| CN101939001A (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| KR20050085681A (ko) | 프로테아제 억제제와 같은 사이토크롬 ｐ450의 억제제와함께 비-뉴클레오시드 역전사효소 억제제(ｎｎｒｔｉ)를함유하는 배합물의 용도 | |
| JP2001515041A5 (https=) | ||
| KR20050075012A (ko) | 항암제에 의해 유발된 말초신경증의 예방 및/또는 치료를위한 아세틸-ｌ-카르니틴 | |
| JP5386478B2 (ja) | パーキンソン病に伴う運動不全の治療のための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用 | |
| WO2004006908A1 (ja) | 色素沈着改善治療薬 | |
| CN1547476A (zh) | Atazanavir在hiv治疗中的用途 | |
| US20110117070A1 (en) | Compositions and methods for treating headache | |
| CN115279344A (zh) | 盐酸米托蒽醌脂质体的用途 | |
| JP2023516753A5 (https=) | ||
| ZA202405485B (en) | Solid oral dosage forms of rabeprazole | |
| CN113557016A (zh) | 衣壳组装调节剂固体配制品 | |
| TWI282735B (en) | Combination and pharmaceutical formulation for the treatment of HBV infection | |
| CN110891574B (zh) | 用于预防和/或治疗肝细胞癌的美格列明 | |
| JP2023531919A5 (https=) |